Staff

TOP 5 publications:

1. Hart X, Amann F, Brand J, Eichentopf L, Gründer G. Low Escitalopram Concentrations in Patients with Depression predict Treatment Failure: A Naturalistic Retrospective Study.Pharmacopsychiatry. 2023 56(2):73-80.
2. Hart XM, Gründer G, Hiemke C, Adamovic I, Amann F, Baumann P, Bergemann N, Brandt C, Clement HW, Conca A, Deckert J, Dietmaier O, Eckermann G, Egberts K, Endres K, Erlacher N, Fekete S, Ferrea S, Florio V, Gerlach M, Haen E, Hahn M, Havemann-Reinecke U, Hefner G, Jost WH, Kuzin M, Laux G, Leucht S, Maniscalco I, Menke A, Messer T, Moessner R, Müller DJ, Müller T, Paulzen M, Petri H, Pfeifer P, Pfuhlmann B, Riederer P, Roll SC, Scherf-Clavel M, Schwarz M, Steimer W, Stingl JC, Toto S, Ulrich S, Zernig G, Zurek G, Unterecker S, Schoretsanitis G. Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspects.Pharmacopsychiatry. 2026 Jul 2. [Epub ahead of print].
3. Amann F, Hefner G, Cremer-Schaeffer P, Gründer G, Häuser W, Hart XM, Petzke F, Zernig G, Havemann-Reinecke U. Therapeutic Drug Monitoring of Cannabinoids: Therapeutic Reference Ranges for Delta-9-tetrahydrocannabinol in Medical Cannabis, Nabiximols, Dronabinol and Nabilone.Pharmacopsychiatry. 2026 Jun 10. [Epub ahead of print].
4. Hart XM, Amann F, Baumann P, Havemann-Reinecke U, Schoretsanitis G, Steimer W, Unterecker S, Zernig G, Gründer G, Hiemke C. How to Determine a Therapeutic Reference Range for a Psychotropic Drug Systematically? Recommendations of the TDM Task Force of the AGNP.Ther Drug Monit. 2025 47(2):199-210. Epub 2025 Feb 14.